biote Corp. (BTMD) 8-K Current Report — March 11, 2026
Filed: March 11, 2026
Health Care
Medicinal Chemicals & Botanical Productsbiote Corp. (BTMD) 8-K current report filed with SEC EDGAR on March 11, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
biote Corp. 8-K Mar 11, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Q4 and full fiscal year 2025 earnings results released March 11, 2026
- • Full financial details in Exhibit 99.1 press release — key figures not disclosed in this item
Get deeper insights on biote Corp.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.